Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Physical Chemistry. B|November 1, 2013
Small-angle neutron scattering study of a monoclonal antibody using free-energy constraintsNicholas J Clark, Hailiang Zhang, Susan Krueger, et al.Journal of Molecular Biology|March 30, 2007
Biophysical characterization of structural properties and folding of interleukin-1 receptor antagonistRamil F Latypov, Timothy S Harvey, Dingjiang Liu, et al.Protein Science : a Publication of the Protein Society|August 6, 2026
Engineered antibodies preserve structural and functional recognition of Plasmodium falciparum circumsporozoite proteinMonika Jain, Sashank Agrawal, Fabien Cannac, et al.Immunity|June 2, 2009
A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1Dirk E Smith, Brian P Lipsky, Chris Russell, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Conformational trapping in a membrane environment: a regulatory mechanism for protein activity?S Arumugam, S Pascal, C L North, et al.Antibody Therapeutics|October 9, 2024
AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsCristina Moldovan Loomis, Thomas Lahlali, Danielle Van Citters, et al.Journal of Pharmaceutical Sciences|July 27, 2019
Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization ActivityBruce A Kerwin, Chelsey Bennett, Yan Brodsky, et al.The Journal of Pharmacology and Experimental Therapeutics|February 6, 2015
Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancementKirk R Henne, Brandon Ason, Monique Howard, et al.Nature Communications|January 29, 2015
ADAM8 as a drug target in pancreatic cancerUwe Schlomann, Garrit Koller, Catharina Conrad, et al.Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.Pageof 4